Recent updates

Item amended Date Amended Amended Reason
5.7.4.2 Allowability of amendments before acceptance

Addition of information related to reliance on cross-references

6.2.1 Procedural Outline - International Type Search

Temporarily removed link to Annex D in Related Chapters section

5.6.2.7 Excess Claims Fees and Invitation to Pay

Corrected broken link under 'On this page'

3.3.2.1 Level of Detail in the Report

Addition of paragraphs relating to level of details in second and later reports

5.6.11.1 Conditions for filing

Correcting criteria requirements for when an application is for a divisional and additional of the same parent can be accepted

5.6.7.2 Clear enough and complete enough disclosure s40(2)(a)

Correcting guidance under plausibility

5.6.7.4 Difference between ‘clear and complete disclosure’ and ‘support’

Changing "serious inconsistency" to "material difference" and other minor typographical updates

5.6.7.5 Best method

Updated FCAFC decision on relevant date for divisional applications

5.6.8.4 Discoveries, Ideas, Scientific Theories, Mere Schemes and Plans

Updating content in view of Aristocrat decision ([2025] FCAFC 131)

5.6.8.20 Annex A - History of Manner of Manufacture

Updating content in view of Aristocrat decision ([2025] FCAFC 131)

5.6.8.6 Computer Implemented Inventions, Mere Schemes, and Business Methods

Updating formatting at [127] paragraph

5.6.8.1 General Principles – Assessing Manner of Manufacture

Updating content in view of Aristocrat decision ([2025] FCAFC 131)

5.6.8.5 Printed Matter

Removing banner note

5.6.8.7 Games and Gaming Machines

Updating content in view of Aristocrat decision ([2025] FCAFC 131)

5.6.8.8 Mathematical Algorithms

Removing banner note

7.12.1.1 Pharmaceutical Substance per se

Updated note to reflect leave to appeal to the HC has been granted

5.7.7.3 Considering amendments as a result of a hearing decision

Updating guidance on examination practice for considering amendments made as a result of a hearing decision.

7.12 Extension of Term of Standard Patents Relating to Pharmaceutical Substances

Removed banner detail about Otsuka case and related processing of EOTs

7.12.1 Section 70 Considerations

Removed banner detail about Otsuka case and related processing of EOTs

5.5.4.7 'For use in', 'when used', and similar wording in claims

Fixing broken links under the On this page menu.

Back to top